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The rule of 10's applied to liver incidentalomas
The availability and increased accessibility of abdominal imaging has led to increased diagnosis of
asymptomatic liver lesions known in the trade as ‘incidentalomas’. The next question that arises is what
to do about them? Jonathan Koea, in his article in this month’s HPB, has examined the referral patterns
and outcomes of a large number of such lesions in Auckland, New Zealand. He found that inciden-
talomas accounted for 10% of all liver cases referred to his practice. The majority of these lesions were
benign, but 10% of all lesions turned out to be malignant. Radiological subclassification on the basis
of perfusion on contrast imaging separated cholangiocarcinomas (low attenuation) from other malig-
nant hepatocellular carcinoma and metastases (high attenuation) and interestingly these formed 10%
of both low and high attenuating lesions. Lurking among the adenomas, focal nodular hyperplasia,
inflammatory nodules, haemangiomas and cysts will be some malignant cancers and it is crucial to
have your radar switched on to detect these. Quality imaging is the key to defining incidentalomas and
contrast MRI scans are particularly helpful in obtaining a confident diagnosis of many of these lesions.
In an unfiltered referral practice the rule of 10s is well worth remembering; 10% of your practice will
be incidentalomas and 10% will prove to be malignant.
Stephen J Wigmore
When judgement probably matters most
Should today’s long embraced practice of postoperative abdominal drainage (Po-Dr) following pan-
createctomy be continued or abandoned? Does Po-Dr reliably prevent or in fact cause complications,
and if so, how often and to what extent? What does the best available evidence tell us? Seeking answers,
van der Wilt et al. from the Netherlands conducted a systematic review of published trials comparing
outcomes after pancreatectomy when Po-Dr was used routinely or not at all. One randomized and two
non-randomized (comparative design) studies that enrolled a total of 494 patients met stringent
inclusion criteria for review. These well-known studies (Heslin 1998, Conlon 2001, Fisher 2011)
evaluated Po-Dr among resections with and without pancreato-enteric anastomoses. Meta-analyses
for proportions of patients suffering major complications were consistently lower in patients without
Po-Dr in all three studies. These differences, however, were not statistically significant, especially after
deeper adjustment for multiple testing and heterogeneity. Secondary endpoints (mortality and length
of stay) could not be properly assessed as requisite data were lacking. You will note that this review
initially identified and screened 206 potentially relevant studies. And so, our available evidence is
inconclusive. Some will wonder how pressing the question is. After all, the motive of Po-Dr is to
control the inherent long-proven morbidity of pancreatectomy. To drain or not to drain? It’s up
to you.
Mark Callery
Delivering quality HPB surgery- the devil is in the detail
In this issue of HPB, Ceppa et al. describe a prospective process improvement initiative in which
surgical site infections were reduced substantially (9.6%) and sustained subsequently in patients
undergoing complex HPB surgery. This process improvement resulted in significant cost savings and
reduced readmissions and length of hospital stay. Surgeons interested in improving individual or
institutional outcomes with regard to HPB surgical site infections, would be well rewarded by spend-
ing time reading the detail of this paper. Although the changes implemented were multi-factorial, key
themes need to be highlighted. Firstly, none of the changes were expensive technological changes or
major technical advances. These represented easily implemented non-technical changes that simply
require the surgical team to pay attention to the detail of perioperative care such as maintaining
intra-operative normothermia, ensuring correct antibiotic usage and minimizing intra-operative
contamination to the operative field. Secondly, individual surgeon feedback was rated by the surgeons
involved as the key factor in achieving the change. The importance of good surgical audit and ‘data
driving behavior’ should not be underestimated and should be a mandatory component of any HPB
program. Thirdly, as has been experienced with enhanced recovery surgery, the improvement was not
achieved by one major change but multiple small changes with the effect seemingly ‘greater than the
sum of all the parts’. If one was to be critical of this paper it is that some of the detail is missing. For
example, what does tight glucose control actually mean and how was it achieved? What did a restricted
approach to blood transfusion entail? It may be the philosophy rather than the detail that is crucial.
Saxon Connor
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